Science Advances · 2020 · 64 citations · 36 references
MedicineOncologyPharmacologyCancer ImmunologyCancer PharmacologyTumor ImmunologyCancer ImmunotherapyTumor Microenvironment ModulationAgonist ActivityCancer Targeting LigandsMetastatic MechanismsMetastatic SignalingNon-small Cell Lung Cancer ImmunotherapyNon-small Cell Lung Cancer Therapy
immune response. Our study demonstrates the promise of poly(2-oxazoline)-formulated Resiquimod for treating metastatic NSCLC.
36
CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes
Edith M. Janssen, Edward E. Lemmens, Tom Wolfe et al. · Nature · 2003 · 1.6K citations